BECTON DICKINSON & CO is 11.3x more valuable than HAEMONETICS CORP by market capitalization ($40.30 B vs $3.55 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HAE | BDX |
|---|---|---|
| Market cap | $3.55 B | $40.30 B |
| US-listed rank | #1690 | #383 |
| Revenue (latest FY) | $1.33B | $21.84B |
| Net income (latest FY) | $97.31M | $1.68B |
| Net margin | 7.3% | 7.7% |
| P/E (trailing FY) | 36.5 | 24.0 |
| SEC filings | 1,875 | 3,027 |
BECTON DICKINSON & CO is 11.3x more valuable than HAEMONETICS CORP by market capitalization ($40.30 B vs $3.55 B).
In their latest fiscal years, HAEMONETICS CORP reported $1.33B in revenue while BECTON DICKINSON & CO reported $21.84B.
Full pages: HAEMONETICS CORP and BECTON DICKINSON & CO, or browse the full rankings.